Creative Biogene proudly announces the launch of its flagship lentiviral vector-based in vivo CAR-T development services, aimed at revolutionizing cancer treatments through precision medicine.

Shirley, NY - November 3, 2026 - Creative Biogene is established by a team of seasoned scientists, quality professionals, and biotechnology service experts.

With unparalleled experience and scientific expertise, our team offers cutting-edge technologies and innovative solutions in method development, validation, and sample testing, driving advancements in drug development and manufacturing.